Vitamin D Analog [EPC]

Vitamin D Analog [EPC] was reported 18032 times

Drugs of the Vitamin D Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ARTERIOVENOUS SHUNT OPERATION 10 0.1961
1 SHUNT THROMBOSIS 15 0.1515
2 ARTERIOVENOUS FISTULA OCCLUSION 21 0.1200
3 ANGIOSCLEROSIS 7 0.1167
4 ARTERIOVENOUS FISTULA SITE INFECTION 14 0.1037
5 PARATHYROIDECTOMY 49 0.1019
6 PEAU D'ORANGE 8 0.0879
7 SKIN FIBROSIS 37 0.0764
8 BLOOD PHOSPHORUS ABNORMAL 36 0.0764
9 ARTERIOVENOUS FISTULA THROMBOSIS 26 0.0751
10 BLOOD PARATHYROID HORMONE ABNORMAL 46 0.0728
11 DIALYSIS RELATED COMPLICATION 25 0.0706
12 MULTIPLE DRUG THERAPY 43 0.0570
13 ARTERIOVENOUS FISTULA OPERATION 15 0.0556
14 SHUNT OCCLUSION 28 0.0551
15 PARATHYROID GLAND ENLARGEMENT 7 0.0490
16 HAEMODIALYSIS COMPLICATION 8 0.0471
17 ARTERIOVENOUS FISTULA SITE COMPLICATION 28 0.0467
18 RENAL TRANSPLANT 168 0.0465
19 CALCIPHYLAXIS 83 0.0452
20 HYPERPARATHYROIDISM SECONDARY 110 0.0439
21 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 11 0.0438
22 NEPHROGENIC SYSTEMIC FIBROSIS 124 0.0410
23 INFARCTION 258 0.0377
24 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 7 0.0374
25 BLOOD PARATHYROID HORMONE INCREASED 107 0.0367
26 ARTERIOVENOUS FISTULA 17 0.0346
27 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 35 0.0330
28 SKIN INDURATION 65 0.0313
29 EXTREMITY CONTRACTURE 19 0.0297
30 PARATHYROID DISORDER 24 0.0296
31 JOINT CONTRACTURE 31 0.0289
32 HYPERTENSIVE CARDIOMYOPATHY 8 0.0288
33 VENOUS STENOSIS 7 0.0278
34 HAEMANGIOMA OF SKIN 12 0.0275
35 LENTIGO 13 0.0262
36 NEPHROGENIC ANAEMIA 120 0.0259
37 SHUNT MALFUNCTION 7 0.0247
38 SKIN HYPERTROPHY 67 0.0238
39 TRANSPLANT 54 0.0227
40 PHOTODERMATOSIS 9 0.0213
41 SEBORRHOEIC KERATOSIS 30 0.0206
42 CEREBROVASCULAR DISORDER 62 0.0206
43 KERATOACANTHOMA 14 0.0205
44 DEVICE RELATED SEPSIS 39 0.0194
45 INFECTED FISTULA 10 0.0187
46 HYPERPHOSPHATAEMIA 39 0.0181
47 GUTTATE PSORIASIS 14 0.0171
48 PULMONARY CALCIFICATION 7 0.0169
49 ENDOCARDITIS BACTERIAL 13 0.0165
50 BLOOD PARATHYROID HORMONE DECREASED 24 0.0162
51 ARACHNOID CYST 6 0.0153
52 PARATHYROID TUMOUR BENIGN 11 0.0148
53 ABDOMINAL SEPSIS 13 0.0148
54 RENAL FAILURE CHRONIC 111 0.0144
55 NAIL DYSTROPHY 8 0.0143
56 VASCULAR CALCIFICATION 14 0.0131
57 FIBROSIS 39 0.0127
58 AORTIC VALVE SCLEROSIS 9 0.0123
59 SKIN TIGHTNESS 57 0.0121
60 SKIN PLAQUE 102 0.0121
61 CATHETER PLACEMENT 22 0.0119
62 CARDIO-RESPIRATORY ARREST 478 0.0114
63 BLOOD PHOSPHORUS INCREASED 31 0.0113
64 MITRAL VALVE CALCIFICATION 7 0.0109
65 PERITONEAL DIALYSIS 9 0.0109
66 BLOOD PRESSURE INADEQUATELY CONTROLLED 65 0.0108
67 DIABETIC FOOT 31 0.0101
68 EXERCISE TOLERANCE DECREASED 58 0.0101
69 DROWNING 10 0.0099
70 END STAGE RENAL DISEASE 179 0.0098
71 XEROSIS 12 0.0097
72 PULMONARY SEPSIS 14 0.0096
73 DEVICE DAMAGE 7 0.0088
74 REBOUND ACID HYPERSECRETION 26 0.0086
75 ACUTE PULMONARY OEDEMA 48 0.0085
76 PAPULE 60 0.0085
77 DEVICE RELATED INFECTION 131 0.0085
78 BLOOD CALCIUM ABNORMAL 14 0.0084
79 IRON OVERLOAD 9 0.0083
80 AZOTAEMIA 33 0.0083
81 CARDIOPULMONARY FAILURE 32 0.0082
82 DACTYLITIS 8 0.0081
83 OSTEOMALACIA 12 0.0078
84 HYPERPARATHYROIDISM 16 0.0078
85 RESPIRATORY ARREST 211 0.0076
86 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 30 0.0073
87 PERITONEAL CLOUDY EFFLUENT 10 0.0073
88 MACULE 20 0.0072
89 BLOOD POTASSIUM ABNORMAL 19 0.0071
90 HYPERCALCAEMIA 88 0.0071
91 NEOPLASM SKIN 11 0.0071
92 BLOOD CALCIUM INCREASED 62 0.0071
93 DIABETIC FOOT INFECTION 10 0.0071
94 ACUTE MYOCARDIAL INFARCTION 206 0.0070
95 CARDIAC DISORDER 642 0.0069
96 CARDIAC DEATH 8 0.0066
97 CARDIOVASCULAR DISORDER 168 0.0066
98 PSORIASIS 863 0.0066
99 ANAEMIA MACROCYTIC 14 0.0066
100 ANEURYSM RUPTURED 6 0.0065
101 KIDNEY ENLARGEMENT 7 0.0064
102 HYPERTENSIVE HEART DISEASE 12 0.0064
103 DISCOURAGEMENT 15 0.0064
104 DISEASE COMPLICATION 29 0.0063
105 LEG AMPUTATION 26 0.0063
106 EXTREMITY NECROSIS 11 0.0063
107 CATHETER SITE INFECTION 22 0.0058
108 HAEMORRHAGIC STROKE 44 0.0056
109 SUDDEN CARDIAC DEATH 19 0.0056
110 VENOUS OCCLUSION 10 0.0055
111 NEPHROPATHY 51 0.0055
112 SEBORRHOEIC DERMATITIS 9 0.0054
113 MUSCLE CONTRACTURE 11 0.0054
114 INTERVERTEBRAL DISCITIS 10 0.0053
115 ISCHAEMIC CARDIOMYOPATHY 16 0.0052
116 UNDERWEIGHT 10 0.0051
117 SUDDEN DEATH 53 0.0050
118 CALCINOSIS 11 0.0049
119 JOINT RANGE OF MOTION DECREASED 66 0.0049
120 BLOOD CREATININE ABNORMAL 17 0.0049
121 SUSPECTED COVID-19 16 0.0048
122 PERITONITIS BACTERIAL 48 0.0048
123 ORTHOPNOEA 15 0.0047
124 LYMPHADENOPATHY MEDIASTINAL 9 0.0047
125 ANGIOPLASTY 7 0.0047
126 APLASIA PURE RED CELL 16 0.0046
127 ACTINIC KERATOSIS 12 0.0046
128 CONCOMITANT DISEASE PROGRESSION 9 0.0046
129 SKIN HYPERPIGMENTATION 39 0.0045
130 HYPERTENSIVE CRISIS 50 0.0045
131 ONYCHOLYSIS 7 0.0045
132 DERMAL CYST 11 0.0045
133 ENTHESOPATHY 7 0.0045
134 SEPSIS 499 0.0045
135 PERIPHERAL VASCULAR DISORDER 23 0.0045
136 CARDIAC FAILURE 356 0.0044
137 DERMATITIS PSORIASIFORM 9 0.0044
138 PERITONEAL DIALYSIS COMPLICATION 32 0.0044
139 HEPATITIS FULMINANT 13 0.0044
140 SOFT TISSUE INFECTION 8 0.0044
141 HAEMODIALYSIS 36 0.0043
142 AORTIC ARTERIOSCLEROSIS 11 0.0043
143 PERITONITIS 88 0.0042
144 DIABETES MELLITUS INADEQUATE CONTROL 75 0.0042
145 DEATH 3608 0.0042
146 ASPHYXIA 34 0.0042
147 PSORIATIC ARTHROPATHY 169 0.0042
148 GANGRENE 25 0.0041
149 MELANOCYTIC NAEVUS 18 0.0041
150 ENDOCARDITIS 21 0.0041
151 WOUND INFECTION STAPHYLOCOCCAL 7 0.0040
152 BLOOD CULTURE POSITIVE 12 0.0040
153 FISTULA 45 0.0040
154 HYPERKERATOSIS 22 0.0040
155 VASODILATATION 10 0.0040
156 AORTIC VALVE STENOSIS 7 0.0039
157 UMBILICAL HERNIA 18 0.0038
158 DIALYSIS 54 0.0038
159 ARTERIOSCLEROSIS CORONARY ARTERY 25 0.0038
160 SKIN NECROSIS 19 0.0037
161 THERAPEUTIC PRODUCT INEFFECTIVE 14 0.0036
162 TACHYARRHYTHMIA 9 0.0036
163 CHRONIC KIDNEY DISEASE 271 0.0036
164 KIDNEY TRANSPLANT REJECTION 17 0.0035
165 MYOCARDIAL INFARCTION 607 0.0035
166 PERIPHERAL ISCHAEMIA 14 0.0034
167 ANGINA UNSTABLE 22 0.0034
168 HYPOVOLAEMIC SHOCK 16 0.0033
169 GUILLAIN-BARRE SYNDROME 16 0.0033
170 PULMONARY OEDEMA 148 0.0033
171 CARDIAC ARREST 272 0.0033
172 ABDOMINAL HERNIA 15 0.0033
173 BLOOD PHOSPHORUS DECREASED 12 0.0033
174 BRAIN DEATH 10 0.0032
175 DIABETIC NEUROPATHY 16 0.0032
176 BRONCHOPNEUMONIA 11 0.0032
177 ARTERIOSCLEROSIS 30 0.0032
178 DIABETIC NEPHROPATHY 7 0.0032
179 ARTERIAL OCCLUSIVE DISEASE 25 0.0032
180 NOSOCOMIAL INFECTION 7 0.0032
181 MYOCARDIAL ISCHAEMIA 36 0.0032
182 CAROTID ARTERY STENOSIS 11 0.0031
183 INGUINAL HERNIA 19 0.0031
184 DEFORMITY 29 0.0031
185 CATHETER SITE PAIN 8 0.0031
186 HYPOCALCAEMIA 58 0.0031
187 ONYCHOCLASIS 21 0.0030
188 THROMBOSIS IN DEVICE 10 0.0030
189 SKIN PAPILLOMA 12 0.0030
190 DIVERTICULUM INTESTINAL 13 0.0030
191 HAEMORRHAGIC ANAEMIA 13 0.0030
192 PUSTULE 7 0.0030
193 SUPRAVENTRICULAR TACHYCARDIA 28 0.0029
194 AORTIC STENOSIS 10 0.0029
195 BLOOD POTASSIUM INCREASED 46 0.0028
196 UROSEPSIS 26 0.0028
197 SCAR 48 0.0028
198 CATHETER SITE HAEMORRHAGE 7 0.0028
199 PEMPHIGOID 21 0.0028
200 FIBULA FRACTURE 8 0.0028
201 SKIN ABRASION 13 0.0027
202 DIABETIC COMPLICATION 7 0.0027
203 PULSE ABSENT 13 0.0027
204 CHOKING SENSATION 15 0.0027
205 LIPOMA 7 0.0027
206 MENINGITIS ASEPTIC 12 0.0027
207 MOBILITY DECREASED 192 0.0027
208 SKIN ULCER 69 0.0027
209 SKIN LESION 73 0.0027
210 EXFOLIATIVE RASH 7 0.0027
211 SQUAMOUS CELL CARCINOMA OF SKIN 16 0.0026
212 GASTRIC INFECTION 10 0.0026
213 FLUID OVERLOAD 38 0.0026
214 SKIN ATROPHY 15 0.0026
215 HYPOTONIA 26 0.0026
216 GASTRITIS EROSIVE 12 0.0026
217 BACTERIAL INFECTION 48 0.0026
218 BACTERAEMIA 30 0.0025
219 MALNUTRITION 28 0.0025
220 ANAL HAEMORRHAGE 7 0.0025
221 RENAL FAILURE 331 0.0025
222 INTRACRANIAL ANEURYSM 10 0.0025
223 OXYGEN SATURATION ABNORMAL 7 0.0025
224 CORONARY ARTERY DISEASE 74 0.0024
225 SQUAMOUS CELL CARCINOMA 23 0.0024
226 STAPHYLOCOCCAL SEPSIS 12 0.0024
227 RESPIRATORY DISTRESS 67 0.0024
228 ISCHAEMIA 11 0.0024
229 CLAVICLE FRACTURE 9 0.0023
230 ABSCESS LIMB 10 0.0023
231 ADVERSE EVENT 216 0.0023
232 GENERALISED OEDEMA 29 0.0023
233 PURULENT DISCHARGE 10 0.0023
234 NECROSIS 13 0.0023
235 METABOLIC ENCEPHALOPATHY 7 0.0023
236 CEREBRAL ISCHAEMIA 12 0.0023
237 HAEMOGLOBIN ABNORMAL 15 0.0023
238 FAILURE TO THRIVE 12 0.0023
239 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 164 0.0023
240 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
241 VENOUS THROMBOSIS 9 0.0023
242 JOINT STIFFNESS 60 0.0023
243 HIP FRACTURE 73 0.0023
244 DIASTOLIC DYSFUNCTION 7 0.0023
245 RENAL CYST 18 0.0023
246 NEOPLASM 26 0.0023
247 ABDOMINAL MASS 6 0.0022
248 ANHEDONIA 58 0.0022
249 SKIN FISSURES 43 0.0022
250 VEIN DISORDER 11 0.0022
251 ECONOMIC PROBLEM 33 0.0022
252 TOE AMPUTATION 11 0.0022
253 MEDICAL DEVICE COMPLICATION 16 0.0022
254 ROSACEA 10 0.0021
255 ANGIOPATHY 12 0.0021
256 OTITIS MEDIA 7 0.0021
257 CARDIOMEGALY 26 0.0021
258 SKIN INJURY 7 0.0021
259 DERMATITIS CONTACT 24 0.0021
260 CARDIAC VALVE DISEASE 12 0.0021
261 SKIN EXFOLIATION 177 0.0021
262 GENERAL PHYSICAL HEALTH DETERIORATION 241 0.0021
263 HYPERKALAEMIA 73 0.0021
264 OCULAR ICTERUS 9 0.0021
265 RESPIRATORY TRACT INFECTION 54 0.0021
266 RALES 12 0.0021
267 DIABETIC RETINOPATHY 7 0.0021
268 BLOOD CALCIUM DECREASED 23 0.0020
269 PUSTULAR PSORIASIS 7 0.0020
270 PARALYSIS 29 0.0020
271 ATYPICAL PNEUMONIA 6 0.0020
272 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
273 URINARY TRACT DISORDER 9 0.0020
274 ARRHYTHMIA 93 0.0020
275 SKIN HAEMORRHAGE 29 0.0020
276 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
277 SPINAL OSTEOARTHRITIS 17 0.0019
278 RENAL INJURY 57 0.0019
279 BLOOD CREATININE DECREASED 6 0.0019
280 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
281 OEDEMA PERIPHERAL 233 0.0019
282 SKIN WARM 11 0.0019
283 CELLULITIS 95 0.0019
284 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
285 HUMERUS FRACTURE 9 0.0019
286 CHOLECYSTITIS 22 0.0018
287 UNEVALUABLE EVENT 139 0.0018
288 DIVERTICULUM 13 0.0018
289 ONYCHOMYCOSIS 8 0.0018
290 BLOOD CREATINE INCREASED 8 0.0018
291 SKIN DISORDER 60 0.0018
292 SKIN MASS 12 0.0018
293 SKIN INFECTION 20 0.0018
294 POSTOPERATIVE WOUND INFECTION 12 0.0018
295 INFECTION 257 0.0018
296 DYSLIPIDAEMIA 9 0.0018
297 RESPIRATORY DISORDER 53 0.0018
298 HYPERLIPIDAEMIA 21 0.0018
299 CEREBROVASCULAR ACCIDENT 297 0.0018
300 CORONARY ARTERY OCCLUSION 24 0.0017
301 GASTRIC HAEMORRHAGE 20 0.0017
302 CARDIAC MURMUR 15 0.0017
303 STAPHYLOCOCCAL INFECTION 57 0.0017
304 FEELING OF DESPAIR 8 0.0017
305 NAIL DISORDER 15 0.0017
306 QUALITY OF LIFE DECREASED 23 0.0017
307 HYPOVOLAEMIA 10 0.0017
308 TIBIA FRACTURE 8 0.0017
309 OVARIAN CYST 17 0.0017
310 BLOOD UREA INCREASED 28 0.0017
311 GOUT 30 0.0017
312 TREATMENT NONCOMPLIANCE 91 0.0017
313 BLOOD PRESSURE ABNORMAL 33 0.0017
314 ENTEROCOCCAL INFECTION 8 0.0017
315 VITAMIN D DECREASED 14 0.0016
316 DEVICE OCCLUSION 23 0.0016
317 UNRESPONSIVE TO STIMULI 42 0.0016
318 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
319 PIGMENTATION DISORDER 10 0.0016
320 INFLAMMATION 83 0.0016
321 HEPATIC CIRRHOSIS 30 0.0016
322 TREATMENT FAILURE 132 0.0016
323 ERYSIPELAS 8 0.0016
324 CORONARY ARTERY STENOSIS 8 0.0016
325 MULTIPLE INJURIES 10 0.0016
326 THERAPY NON-RESPONDER 71 0.0016
327 AORTIC ANEURYSM 12 0.0016
328 GASTROENTERITIS 23 0.0016
329 WHEELCHAIR USER 7 0.0016
330 MASS 22 0.0016
331 PHARYNGITIS STREPTOCOCCAL 17 0.0016
332 PROCEDURAL COMPLICATION 12 0.0016
333 CACHEXIA 8 0.0016
334 STOMACH DISCOMFORT 8 0.0015
335 EXOSTOSIS 14 0.0015
336 DEPRESSED MOOD 81 0.0015
337 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
338 POLYP 10 0.0015
339 HAEMATOCRIT DECREASED 30 0.0015
340 LOCALISED OEDEMA 7 0.0015
341 BLOOD ALBUMIN DECREASED 12 0.0015
342 RENAL FUNCTION TEST ABNORMAL 7 0.0015
343 RENAL DISORDER 70 0.0015
344 MOUTH HAEMORRHAGE 11 0.0015
345 SKIN SWELLING 13 0.0015
346 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
347 GASTRITIS 39 0.0015
348 COGNITIVE DISORDER 69 0.0015
349 POST PROCEDURAL INFECTION 12 0.0015
350 OEDEMA 80 0.0015
351 CARDIAC TAMPONADE 7 0.0015
352 MOTOR DYSFUNCTION 15 0.0015
353 ANGINA PECTORIS 42 0.0015
354 ISCHAEMIC STROKE 26 0.0015
355 PAIN OF SKIN 39 0.0014
356 MULTI-ORGAN FAILURE 25 0.0014
357 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
358 VENTRICULAR FIBRILLATION 16 0.0014
359 FOLLICULITIS 15 0.0014
360 RENAL TUBULAR NECROSIS 14 0.0014
361 BREATH SOUNDS ABNORMAL 7 0.0014
362 SKIN DISCOLOURATION 65 0.0014
363 LOCALISED INFECTION 34 0.0014
364 CONTUSION 135 0.0014
365 PRODUCT DISTRIBUTION ISSUE 13 0.0014
366 FLUID INTAKE REDUCED 7 0.0014
367 DERMATITIS EXFOLIATIVE 7 0.0014
368 RESPIRATORY FAILURE 102 0.0014
369 WOUND 39 0.0014
370 MEDICATION ERROR 77 0.0014
371 PERICARDIAL EFFUSION 32 0.0014
372 DERMATITIS 29 0.0014
373 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
374 GASTROINTESTINAL HAEMORRHAGE 115 0.0014
375 HYPERTENSION 291 0.0014
376 CARDIAC FAILURE CONGESTIVE 110 0.0014
377 FEMORAL NECK FRACTURE 7 0.0014
378 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
379 POST PROCEDURAL COMPLICATION 26 0.0014
380 CEREBRAL DISORDER 10 0.0014
381 BONE PAIN 79 0.0013
382 ABASIA 33 0.0013
383 BLOOD CREATININE INCREASED 87 0.0013
384 ACUTE CORONARY SYNDROME 11 0.0013
385 REBOUND EFFECT 15 0.0013
386 PLEURAL EFFUSION 80 0.0013
387 RENAL IMPAIRMENT 110 0.0013
388 BODY HEIGHT DECREASED 14 0.0013
389 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
390 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
391 ARTHRITIS INFECTIVE 6 0.0013
392 ASCITES 38 0.0013
393 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
394 AMNESIA 84 0.0013
395 PULMONARY CONGESTION 17 0.0013
396 GALLBLADDER DISORDER 23 0.0013
397 SKIN LACERATION 14 0.0013
398 THIRST 23 0.0013
399 BASAL CELL CARCINOMA 20 0.0013
400 SPINAL PAIN 15 0.0013
401 FLUID RETENTION 65 0.0013
402 THERAPEUTIC RESPONSE DECREASED 77 0.0013
403 PYELONEPHRITIS 11 0.0013
404 THERMAL BURN 9 0.0013
405 FURUNCLE 10 0.0013
406 COAGULOPATHY 21 0.0013
407 SINUS CONGESTION 17 0.0013
408 STREPTOCOCCAL INFECTION 7 0.0013
409 ROTATOR CUFF SYNDROME 16 0.0012
410 ATELECTASIS 12 0.0012
411 SEPTIC SHOCK 54 0.0012
412 THYROID DISORDER 19 0.0012
413 CHOKING 24 0.0012
414 DECUBITUS ULCER 10 0.0012
415 OSTEOMYELITIS 22 0.0012
416 HAEMOGLOBIN DECREASED 124 0.0012
417 ELECTROLYTE IMBALANCE 14 0.0012
418 RASH PAPULAR 27 0.0012
419 HEMIPLEGIA 10 0.0012
420 CARDIAC FAILURE ACUTE 8 0.0012
421 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
422 ULCER 19 0.0012
423 IRON DEFICIENCY ANAEMIA 11 0.0012
424 CHOLELITHIASIS 39 0.0012
425 WOUND INFECTION 13 0.0012
426 LABORATORY TEST ABNORMAL 35 0.0012
427 CARDIOGENIC SHOCK 17 0.0012
428 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
429 PNEUMONIA 378 0.0012
430 HEARING IMPAIRED 7 0.0012
431 TYPE 1 DIABETES MELLITUS 7 0.0012
432 PRURITUS GENERALISED 25 0.0012
433 LARGE INTESTINE POLYP 8 0.0012
434 PULMONARY HYPERTENSION 24 0.0012
435 LARGE INTESTINE PERFORATION 8 0.0012
436 TENDERNESS 12 0.0012
437 TENSION 7 0.0011
438 MITRAL VALVE INCOMPETENCE 13 0.0011
439 HAEMATEMESIS 29 0.0011
440 BEDRIDDEN 15 0.0011
441 INTERNAL HAEMORRHAGE 13 0.0011
442 CHEST PAIN 210 0.0011
443 RESPIRATORY TRACT CONGESTION 18 0.0011
444 TRICUSPID VALVE INCOMPETENCE 9 0.0011
445 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
446 ABSCESS 18 0.0011
447 UPPER RESPIRATORY TRACT INFECTION 52 0.0011
448 RENAL FAILURE ACUTE 47 0.0011
449 CHROMATURIA 25 0.0011
450 MUSCULOSKELETAL CHEST PAIN 17 0.0011
451 ANKLE FRACTURE 17 0.0011
452 DISCOMFORT 67 0.0011
453 UTERINE LEIOMYOMA 8 0.0011
454 LUNG INFECTION 17 0.0011
455 OSTEOPOROSIS 45 0.0011
456 AUTISM SPECTRUM DISORDER 6 0.0011
457 THERAPY PARTIAL RESPONDER 17 0.0011
458 ACUTE KIDNEY INJURY 166 0.0011
459 BLOOD GLUCOSE ABNORMAL 20 0.0011
460 HYPOPHOSPHATAEMIA 8 0.0011
461 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
462 ARTHROPOD BITE 8 0.0011
463 COORDINATION ABNORMAL 15 0.0011
464 COLON CANCER 16 0.0011
465 NODULE 14 0.0011
466 DRY MOUTH 87 0.0011
467 FLANK PAIN 10 0.0011
468 RASH ERYTHEMATOUS 51 0.0011
469 IMMUNE SYSTEM DISORDER 14 0.0011
470 LUNG DISORDER 52 0.0011
471 SCAB 12 0.0011
472 ROAD TRAFFIC ACCIDENT 44 0.0011
473 HAEMATURIA 36 0.0011
474 LEUKOCYTOSIS 19 0.0010
475 MUSCLE TIGHTNESS 17 0.0010
476 CARDIAC OPERATION 9 0.0010
477 MENTAL STATUS CHANGES 29 0.0010
478 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
479 HEAD INJURY 33 0.0010
480 HAEMATOMA 27 0.0010
481 MUSCULOSKELETAL STIFFNESS 91 0.0010
482 ATRIOVENTRICULAR BLOCK 8 0.0010
483 LIMB DISCOMFORT 32 0.0010
484 ABDOMINAL DISCOMFORT 173 0.0010
485 VITAMIN D DEFICIENCY 10 0.0010
486 HAEMORRHOIDS 20 0.0010
487 PRURITUS 393 0.0010
488 ECCHYMOSIS 7 0.0010
489 CYANOSIS 16 0.0010
490 PURPURA 9 0.0010
491 CARDIOMYOPATHY 15 0.0010
492 HYPOTENSION 203 0.0010
493 LIGAMENT SPRAIN 10 0.0010
494 BLOOD PRESSURE DECREASED 67 0.0010
495 THROMBOSIS 81 0.0010
496 GASTROINTESTINAL INFECTION 9 0.0010
497 ANAEMIA 191 0.0010
498 TRANSPLANT REJECTION 8 0.0010
499 BLOOD DISORDER 8 0.0010
500 RASH PRURITIC 54 0.0010
501 SLEEP APNOEA SYNDROME 19 0.0010
502 SENSORY LOSS 8 0.0010
503 DUODENAL ULCER 7 0.0010
504 EMPHYSEMA 10 0.0010
505 FUNGAL INFECTION 33 0.0010
506 BURSITIS 12 0.0010
507 ORAL CANDIDIASIS 13 0.0010
508 TOOTH INFECTION 13 0.0010
509 DIABETES MELLITUS 75 0.0010
510 PRODUCT SUPPLY ISSUE 7 0.0010
511 BRADYCARDIA 52 0.0010
512 SUBDURAL HAEMATOMA 14 0.0010
513 SKIN CANCER 21 0.0010
514 MUSCULAR WEAKNESS 110 0.0010
515 PAIN IN EXTREMITY 284 0.0010
516 APPENDICITIS 9 0.0010
517 EMBOLISM 8 0.0010
518 RASH PUSTULAR 7 0.0010
519 SYNCOPE 96 0.0010
520 LIMB INJURY 26 0.0010
521 TRANSFUSION 10 0.0010
522 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
523 SCRATCH 10 0.0009
524 ABDOMINAL PAIN 220 0.0009
525 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 16 0.0009
526 PERIPHERAL SWELLING 145 0.0009
527 PULMONARY MASS 14 0.0009
528 SPLENOMEGALY 11 0.0009
529 SUNBURN 7 0.0009
530 HYPOPHAGIA 24 0.0009
531 ACUTE RESPIRATORY FAILURE 18 0.0009
532 PSEUDOMONAS INFECTION 8 0.0009
533 ANOREXIA 12 0.0009
534 HIATUS HERNIA 12 0.0009
535 ATRIAL FIBRILLATION 90 0.0009
536 ARTHRALGIA 383 0.0009
537 OSTEOARTHRITIS 39 0.0009
538 PALLOR 25 0.0009
539 HEPATOMEGALY 9 0.0009
540 RASH MACULAR 32 0.0009
541 FALL 303 0.0009
542 GRIP STRENGTH DECREASED 8 0.0009
543 URINARY TRACT INFECTION 155 0.0009
544 HAEMOLYSIS 7 0.0009
545 ARTHRITIS 71 0.0009
546 APHTHOUS ULCER 7 0.0009
547 HYPOALBUMINAEMIA 7 0.0009
548 PELVIC FRACTURE 7 0.0009
549 DYSURIA 33 0.0009
550 GASTRIC ULCER 17 0.0009
551 PROTEINURIA 17 0.0009
552 GASTROINTESTINAL INFLAMMATION 7 0.0009
553 GAIT DISTURBANCE 171 0.0009
554 MUSCULOSKELETAL DISORDER 17 0.0009
555 FACE OEDEMA 15 0.0009
556 PULMONARY FIBROSIS 17 0.0009
557 GASTROENTERITIS VIRAL 16 0.0009
558 ASTHENIA 331 0.0009
559 IMPAIRED GASTRIC EMPTYING 12 0.0009
560 HERNIA 17 0.0009
561 SCIATICA 14 0.0009
562 HIDRADENITIS 8 0.0009
563 DYSPNOEA 495 0.0009
564 FEMUR FRACTURE 27 0.0009
565 NERVE COMPRESSION 8 0.0009
566 LOSS OF CONSCIOUSNESS 111 0.0009
567 PRESYNCOPE 21 0.0009
568 MELAENA 19 0.0009
569 ERYTHEMA 177 0.0009
570 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
571 UPPER LIMB FRACTURE 17 0.0009
572 HYPERAESTHESIA 7 0.0009
573 HAEMORRHAGE 89 0.0009
574 BLINDNESS UNILATERAL 12 0.0008
575 DYSARTHRIA 32 0.0008
576 HIP ARTHROPLASTY 13 0.0008
577 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
578 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
579 DECREASED ACTIVITY 9 0.0008
580 RIB FRACTURE 17 0.0008
581 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 43 0.0008
582 BONE DISORDER 15 0.0008
583 CATARACT 49 0.0008
584 ASPIRATION 9 0.0008
585 NO THERAPEUTIC RESPONSE 10 0.0008
586 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 45 0.0008
587 DIARRHOEA 528 0.0008
588 APPLICATION SITE PAIN 18 0.0008
589 BODY TEMPERATURE DECREASED 8 0.0008
590 VIRAL INFECTION 27 0.0008
591 BRONCHITIS 60 0.0008
592 CEREBRAL HAEMORRHAGE 29 0.0008
593 HOSPICE CARE 8 0.0008
594 DISORIENTATION 32 0.0008
595 URINE OUTPUT DECREASED 7 0.0008
596 PAIN 491 0.0008
597 SECRETION DISCHARGE 10 0.0008
598 DRUG INEFFECTIVE 1049 0.0008
599 JOINT INJURY 17 0.0008
600 VOMITING 372 0.0008
601 HAEMOPTYSIS 22 0.0008
602 VENTRICULAR TACHYCARDIA 13 0.0008
603 SUBARACHNOID HAEMORRHAGE 8 0.0008
604 CHILLS 92 0.0008
605 SHOCK 18 0.0008
606 DYSGEUSIA 58 0.0008
607 SINUSITIS 80 0.0008
608 PYREXIA 268 0.0008
609 LUPUS-LIKE SYNDROME 7 0.0008
610 RECTAL HAEMORRHAGE 33 0.0008
611 HEMIPARESIS 13 0.0008
612 PLATELET COUNT INCREASED 10 0.0008
613 RASH 334 0.0008
614 BLOOD PRESSURE INCREASED 117 0.0008
615 MUSCULOSKELETAL PAIN 40 0.0008
616 HYPOGLYCAEMIA 37 0.0008
617 PNEUMONIA BACTERIAL 7 0.0008
618 PNEUMONIA ASPIRATION 19 0.0008
619 PROCEDURAL PAIN 21 0.0008
620 WHITE BLOOD CELL COUNT INCREASED 29 0.0008
621 TACHYCARDIA 67 0.0008
622 CYSTITIS 24 0.0008
623 EMOTIONAL DISTRESS 91 0.0008
624 PRODUCT DOSE OMISSION 49 0.0007
625 DIARRHOEA HAEMORRHAGIC 7 0.0007
626 MOVEMENT DISORDER 24 0.0007
627 FOOT FRACTURE 14 0.0007
628 IMMUNODEFICIENCY 11 0.0007
629 COLD SWEAT 13 0.0007
630 BACK INJURY 8 0.0007
631 LYMPHADENOPATHY 26 0.0007
632 DRUG ERUPTION 13 0.0007
633 HYPERSOMNIA 21 0.0007
634 MUSCLE SPASTICITY 9 0.0007
635 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
636 BACK PAIN 170 0.0007
637 HEPATIC FAILURE 22 0.0007
638 LOWER LIMB FRACTURE 14 0.0007
639 GASTRIC DISORDER 25 0.0007
640 PERIPHERAL COLDNESS 10 0.0007
641 HYPOAESTHESIA 109 0.0007
642 OSTEOPENIA 11 0.0007
643 SKIN IRRITATION 33 0.0007
644 DRY SKIN 96 0.0007
645 ILLNESS 74 0.0007
646 PHARYNGEAL OEDEMA 11 0.0007
647 PRODUCT USE IN UNAPPROVED INDICATION 177 0.0007
648 SNEEZING 16 0.0007
649 LETHARGY 41 0.0007
650 JOINT SWELLING 86 0.0007
651 ECZEMA 37 0.0007
652 MICTURITION URGENCY 8 0.0007
653 MYALGIA 119 0.0007
654 INFUSION SITE PAIN 9 0.0007
655 BRAIN INJURY 7 0.0007
656 NECK PAIN 39 0.0007
657 RASH GENERALISED 18 0.0007
658 PNEUMOTHORAX 11 0.0007
659 PARAESTHESIA ORAL 10 0.0007
660 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
661 BLOOD GLUCOSE DECREASED 33 0.0007
662 C-REACTIVE PROTEIN INCREASED 25 0.0007
663 FRACTURE 13 0.0007
664 BLOOD URINE PRESENT 13 0.0007
665 BURNING SENSATION 48 0.0007
666 SARS-COV-2 TEST POSITIVE 9 0.0007
667 NASAL CONGESTION 40 0.0007
668 BLISTER 38 0.0007
669 GLAUCOMA 13 0.0007
670 INFLUENZA 75 0.0007
671 MALIGNANT MELANOMA 9 0.0007
672 PRODUCTIVE COUGH 32 0.0007
673 IMPAIRED HEALING 22 0.0007
674 WRIST FRACTURE 8 0.0007
675 FREQUENT BOWEL MOVEMENTS 18 0.0007
676 PHOTOSENSITIVITY REACTION 11 0.0007
677 ABDOMINAL PAIN UPPER 136 0.0007
678 NAUSEA 519 0.0007
679 COVID-19 115 0.0007
680 NEPHROLITHIASIS 30 0.0007
681 INSURANCE ISSUE 10 0.0007
682 FEELING HOT 40 0.0007
683 CANDIDA INFECTION 11 0.0007
684 DIVERTICULITIS 18 0.0006
685 SEIZURE 75 0.0006
686 ARTHROPATHY 36 0.0006
687 CONJUNCTIVITIS 12 0.0006
688 HYPOMAGNESAEMIA 9 0.0006
689 TENDONITIS 10 0.0006
690 PHARYNGITIS 8 0.0006
691 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
692 ILEUS 8 0.0006
693 COUGH 180 0.0006
694 OESOPHAGITIS 7 0.0006
695 SWOLLEN TONGUE 20 0.0006
696 INJURY 45 0.0006
697 MUSCULOSKELETAL DISCOMFORT 11 0.0006
698 DERMATITIS ALLERGIC 8 0.0006
699 HAEMATOCHEZIA 35 0.0006
700 SINUS TACHYCARDIA 9 0.0006
701 DRUG EFFECT INCOMPLETE 23 0.0006
702 MUSCLE ATROPHY 8 0.0006
703 MIGRAINE 60 0.0006
704 HERPES ZOSTER 36 0.0006
705 METABOLIC ACIDOSIS 20 0.0006
706 GASTROINTESTINAL DISORDER 56 0.0006
707 HEADACHE 391 0.0006
708 MYELODYSPLASTIC SYNDROME 9 0.0006
709 HYPERTHYROIDISM 9 0.0006
710 HYPOKINESIA 9 0.0006
711 MALAISE 271 0.0006
712 DYSSTASIA 18 0.0006
713 DECREASED APPETITE 143 0.0006
714 KIDNEY INFECTION 12 0.0006
715 SPEECH DISORDER 32 0.0006
716 PULMONARY EMBOLISM 58 0.0006
717 METASTASES TO BONE 10 0.0006
718 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
719 COLITIS 23 0.0006
720 SINUS DISORDER 12 0.0006
721 OXYGEN SATURATION DECREASED 34 0.0006
722 ABDOMINAL DISTENSION 63 0.0006
723 POST PROCEDURAL HAEMORRHAGE 7 0.0006
724 EAR INFECTION 16 0.0006
725 FAECES DISCOLOURED 13 0.0006
726 NEOPLASM MALIGNANT 40 0.0006
727 PRODUCT PRESCRIBING ISSUE 13 0.0006
728 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
729 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
730 CONTRAINDICATED PRODUCT ADMINISTERED 18 0.0006
731 FATIGUE 461 0.0006
732 DIZZINESS 293 0.0006
733 CONSTIPATION 128 0.0006
734 TOOTH DISORDER 13 0.0006
735 DYSPNOEA EXERTIONAL 22 0.0006
736 HYPERHIDROSIS 75 0.0006
737 CONVULSION 33 0.0006
738 DEVICE DEFECTIVE 10 0.0006
739 WEIGHT DECREASED 161 0.0006
740 HYPERGLYCAEMIA 21 0.0006
741 PANIC ATTACK 21 0.0006
742 NEURALGIA 14 0.0006
743 FEELING COLD 16 0.0006
744 MENTAL DISORDER 25 0.0006
745 BRAIN FOG 9 0.0006
746 URINARY INCONTINENCE 17 0.0006
747 CEREBRAL INFARCTION 14 0.0006
748 ANXIETY 163 0.0006
749 DEHYDRATION 76 0.0006
750 NASOPHARYNGITIS 105 0.0006
751 SEASONAL ALLERGY 8 0.0006
752 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
753 RETCHING 12 0.0006
754 LACRIMATION INCREASED 17 0.0006
755 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
756 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
757 OROPHARYNGEAL PAIN 52 0.0006
758 IMPAIRED QUALITY OF LIFE 8 0.0006
759 SWELLING FACE 36 0.0006
760 RHABDOMYOLYSIS 23 0.0006
761 RESTLESS LEGS SYNDROME 10 0.0005
762 SPINAL FRACTURE 11 0.0005
763 RESTLESSNESS 20 0.0005
764 COMA 26 0.0005
765 SURGERY 32 0.0005
766 MUSCLE SPASMS 100 0.0005
767 RHINORRHOEA 35 0.0005
768 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
769 DYSPEPSIA 53 0.0005
770 GAIT INABILITY 18 0.0005
771 DYSPHAGIA 51 0.0005
772 DEPRESSION 122 0.0005
773 ORAL PAIN 12 0.0005
774 HAEMORRHAGE INTRACRANIAL 8 0.0005
775 FIBROMYALGIA 13 0.0005
776 SWELLING 50 0.0005
777 BLOOD POTASSIUM DECREASED 16 0.0005
778 DERMATITIS ATOPIC 28 0.0005
779 HYPOAESTHESIA ORAL 8 0.0005
780 SKIN BURNING SENSATION 38 0.0005
781 APHASIA 16 0.0005
782 PALPITATIONS 62 0.0005
783 ENCEPHALOPATHY 13 0.0005
784 DEVICE ISSUE 47 0.0005
785 CONDITION AGGRAVATED 158 0.0005
786 EJECTION FRACTION DECREASED 8 0.0005
787 HOSPITALISATION 79 0.0005
788 DRUG TOXICITY 7 0.0005
789 POOR QUALITY SLEEP 11 0.0005
790 LIP SWELLING 17 0.0005
791 PRODUCT DOSE OMISSION ISSUE 150 0.0005
792 PARAESTHESIA 80 0.0005
793 ATAXIA 6 0.0005
794 HALLUCINATION, AUDITORY 8 0.0005
795 OBESITY 8 0.0005
796 FEELING ABNORMAL 120 0.0005
797 DIABETIC KETOACIDOSIS 12 0.0005
798 SENSORY DISTURBANCE 8 0.0005
799 TOOTHACHE 9 0.0005
800 SKIN REACTION 7 0.0005
801 CONFUSIONAL STATE 80 0.0005
802 EPISTAXIS 37 0.0005
803 NEUROPATHY PERIPHERAL 47 0.0005
804 VERTIGO 30 0.0005
805 BACK DISORDER 8 0.0005
806 BRONCHOSPASM 7 0.0005
807 RED BLOOD CELL COUNT DECREASED 14 0.0005
808 CHEST DISCOMFORT 50 0.0005
809 HYPOACUSIS 21 0.0005
810 LUNG NEOPLASM MALIGNANT 20 0.0005
811 HEPATIC STEATOSIS 9 0.0005
812 EXPIRED PRODUCT ADMINISTERED 16 0.0005
813 THROAT TIGHTNESS 13 0.0005
814 DYSPHONIA 28 0.0005
815 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
816 BLOOD SODIUM DECREASED 9 0.0005
817 PANCREATITIS 25 0.0005
818 CIRCULATORY COLLAPSE 8 0.0005
819 IRRITABLE BOWEL SYNDROME 10 0.0005
820 HYPERSENSITIVITY 86 0.0005
821 BALANCE DISORDER 40 0.0005
822 DEEP VEIN THROMBOSIS 30 0.0005
823 BLOOD PRESSURE FLUCTUATION 11 0.0005
824 APPLICATION SITE ERYTHEMA 12 0.0005
825 PRODUCT USE ISSUE 86 0.0005
826 EYE DISORDER 15 0.0005
827 HEART RATE DECREASED 16 0.0005
828 WHEEZING 27 0.0005
829 ANKYLOSING SPONDYLITIS 6 0.0005
830 HYPOKALAEMIA 21 0.0005
831 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
832 INSOMNIA 120 0.0005
833 NERVOUS SYSTEM DISORDER 14 0.0004
834 TYPE 2 DIABETES MELLITUS 15 0.0004
835 DEVICE MALFUNCTION 31 0.0004
836 FLATULENCE 25 0.0004
837 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
838 VISUAL IMPAIRMENT 54 0.0004
839 HEART RATE INCREASED 43 0.0004
840 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 78 0.0004
841 EYE SWELLING 16 0.0004
842 LIVER DISORDER 19 0.0004
843 BLOOD TEST ABNORMAL 6 0.0004
844 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
845 DIPLOPIA 11 0.0004
846 ACNE 32 0.0004
847 TREMOR 70 0.0004
848 DEAFNESS 11 0.0004
849 SEDATION 11 0.0004
850 PRODUCT PRESCRIBING ERROR 10 0.0004
851 INCORRECT ROUTE OF DRUG ADMINISTRATION 15 0.0004
852 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
853 DRUG INTOLERANCE 40 0.0004
854 INFLUENZA LIKE ILLNESS 34 0.0004
855 EAR PAIN 8 0.0004
856 ORAL HERPES 8 0.0004
857 JAUNDICE 11 0.0004
858 DRUG EFFECT DECREASED 22 0.0004
859 VISION BLURRED 56 0.0004
860 BLOOD BILIRUBIN INCREASED 11 0.0004
861 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
862 LOCAL SWELLING 7 0.0004
863 ABORTION SPONTANEOUS 16 0.0004
864 HEART RATE IRREGULAR 9 0.0004
865 METASTASES TO LIVER 7 0.0004
866 HYPOXIA 14 0.0004
867 FULL BLOOD COUNT DECREASED 8 0.0004
868 SLEEP DISORDER 28 0.0004
869 PLATELET COUNT DECREASED 42 0.0004
870 DRUG DOSE OMISSION 65 0.0004
871 BODY TEMPERATURE INCREASED 8 0.0004
872 VAGINAL HAEMORRHAGE 17 0.0004
873 INJECTION SITE BRUISING 31 0.0004
874 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
875 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
876 LIVER FUNCTION TEST ABNORMAL 11 0.0004
877 BLOOD GLUCOSE INCREASED 71 0.0004
878 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
879 DELIRIUM 13 0.0004
880 IMPAIRED WORK ABILITY 8 0.0004
881 INTESTINAL OBSTRUCTION 14 0.0004
882 MENTAL IMPAIRMENT 9 0.0004
883 MEMORY IMPAIRMENT 51 0.0004
884 FEELING JITTERY 7 0.0004
885 ERUCTATION 7 0.0004
886 POLLAKIURIA 15 0.0004
887 URINARY RETENTION 12 0.0004
888 PLASMA CELL MYELOMA 14 0.0004
889 ABDOMINAL PAIN LOWER 9 0.0004
890 HYPONATRAEMIA 20 0.0004
891 PAIN IN JAW 10 0.0004
892 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
893 DYSKINESIA 14 0.0003
894 BONE MARROW FAILURE 7 0.0003
895 BLINDNESS 14 0.0003
896 DRY EYE 17 0.0003
897 ANGIOEDEMA 15 0.0003
898 FLUSHING 34 0.0003
899 ADVERSE DRUG REACTION 30 0.0003
900 HEPATIC CANCER 8 0.0003
901 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
902 THERAPY CESSATION 17 0.0003
903 THROMBOCYTOPENIA 37 0.0003
904 ILL-DEFINED DISORDER 20 0.0003
905 EATING DISORDER 7 0.0003
906 TINNITUS 15 0.0003
907 LIVER INJURY 8 0.0003
908 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
909 HEPATIC ENZYME INCREASED 22 0.0003
910 PANCYTOPENIA 18 0.0003
911 ALOPECIA 63 0.0003
912 AGEUSIA 8 0.0003
913 LEUKOPENIA 16 0.0003
914 OFF LABEL USE 279 0.0003
915 SOMNOLENCE 64 0.0003
916 PRODUCT COMPLAINT 8 0.0003
917 HYPOTHYROIDISM 10 0.0003
918 URTICARIA 52 0.0003
919 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
920 APPLICATION SITE PRURITUS 7 0.0003
921 MUCOSAL INFLAMMATION 8 0.0003
922 CRYING 11 0.0003
923 DRUG INTERACTION 48 0.0003
924 WEIGHT INCREASED 67 0.0003
925 GYNAECOMASTIA 9 0.0003
926 OSTEONECROSIS OF JAW 7 0.0003
927 EXTRAPYRAMIDAL DISORDER 7 0.0003
928 PANCREATIC CARCINOMA 8 0.0003
929 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
930 OSTEONECROSIS 9 0.0003
931 VISUAL ACUITY REDUCED 9 0.0003
932 MATERNAL EXPOSURE DURING PREGNANCY 24 0.0003
933 HALLUCINATION 20 0.0003
934 EPILEPSY 8 0.0003
935 DRUG ADMINISTRATION ERROR 8 0.0003
936 PNEUMONITIS 7 0.0003
937 MOOD ALTERED 7 0.0003
938 BONE DENSITY DECREASED 8 0.0003
939 ANAPHYLACTIC REACTION 14 0.0003
940 DEMENTIA 7 0.0003
941 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
942 EYE PRURITUS 8 0.0002
943 INJECTION SITE HAEMORRHAGE 19 0.0002
944 PROSTATE CANCER 19 0.0002
945 AGITATION 17 0.0002
946 INJECTION SITE PAIN 71 0.0002
947 NERVOUSNESS 12 0.0002
948 DISEASE PROGRESSION 27 0.0002
949 EMOTIONAL DISORDER 7 0.0002
950 HOT FLUSH 17 0.0002
951 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
952 SUICIDAL IDEATION 20 0.0002
953 NIGHT SWEATS 7 0.0002
954 LACTIC ACIDOSIS 7 0.0002
955 BLOOD CHOLESTEROL INCREASED 10 0.0002
956 EYE PAIN 12 0.0002
957 INFUSION RELATED REACTION 14 0.0002
958 INCORRECT DOSE ADMINISTERED 48 0.0002
959 THERAPY INTERRUPTED 15 0.0002
960 INJECTION SITE ERYTHEMA 26 0.0002
961 DEVICE DISLOCATION 9 0.0002
962 ANGER 7 0.0002
963 INTERSTITIAL LUNG DISEASE 10 0.0002
964 PRODUCT STORAGE ERROR 18 0.0002
965 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
966 NIGHTMARE 7 0.0002
967 ASTHMA 22 0.0002
968 OCULAR HYPERAEMIA 9 0.0002
969 DISEASE RECURRENCE 9 0.0002
970 INJECTION SITE REACTION 13 0.0002
971 BLADDER CANCER 11 0.0002
972 STOMATITIS 11 0.0002
973 INJECTION SITE PRURITUS 12 0.0002
974 UNDERDOSE 13 0.0002
975 ABNORMAL BEHAVIOUR 7 0.0002
976 AGGRESSION 8 0.0002
977 RENAL CANCER 7 0.0001
978 NO ADVERSE EVENT 26 0.0001
979 RHEUMATOID ARTHRITIS 16 0.0001
980 PRODUCT QUALITY ISSUE 19 0.0001
981 PRODUCT SUBSTITUTION ISSUE 8 0.0001
982 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
983 FEBRILE NEUTROPENIA 9 0.0001
984 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
985 IRRITABILITY 8 0.0001
986 BREAST CANCER 12 0.0001
987 INTENTIONAL PRODUCT MISUSE 11 0.0001
988 OVERDOSE 25 0.0001
989 EXPOSURE DURING PREGNANCY 7 0.0001
990 TOXICITY TO VARIOUS AGENTS 18 0.0001
991 NEUTROPENIA 14 0.0001
992 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
993 INJECTION SITE SWELLING 7 0.0001
994 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001